Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
06 July 1965Website:
http://www.perkinelmer.comNext earnings report:
01 August 2024Last dividends:
18 April 2024Next dividends:
19 July 2024Price
after hours | Tue, 02 Jul 2024 21:16:11 GMTAnalysts recommendations
Institutional Ownership
RVTY Latest News
Revvity's (RVTY) strong product portfolio raises optimism about the stock.
Revity (RVTY) reported a decrease in life sciences segment revenues in the first quarter, but exceeded expectations for both earnings and revenues.
While the financial results of Revvity (RVTY) in the quarter ending March 2024 provide an overview of the business performance, it may be beneficial to analyze how certain key metrics stack up against Wall Street projections and figures from the previous year.
Revvity (RVTY) reported quarterly earnings of $0.98 per share, surpassing the Zacks Consensus Estimate of $0.94 per share. This is lower than the earnings of $1.01 per share from the previous year.
On Monday, Revvity surpassed Wall Street expectations for its quarterly profit and revenue, thanks to stronger-than-anticipated demand for equipment in its diagnostics division.
Revvity's (RVTY) newest product is expected to enhance workflow, reduce manual labor, and boost productivity in the lab.
Revvity's (RVTY) newest product is expected to greatly speed up drug innovation by streamlining data sharing onto a single platform.
Revvity (RVTY) experienced a significant increase in its stock price in the previous session, accompanied by above-average trading volume. The recent changes in earnings estimates may not lead to additional price growth in the short run.
Revvity's (RVTY) strong product portfolio raises optimism about the stock.
Revvity's (RVTY) latest next-generation suite is likely to enhance research productivity and innovation.
- 1(current)
- 2
What type of business is Revvity?
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
What sector is Revvity in?
Revvity is in the Healthcare sector
What industry is Revvity in?
Revvity is in the Diagnostics & Research industry
What country is Revvity from?
Revvity is headquartered in United States
When did Revvity go public?
Revvity initial public offering (IPO) was on 06 July 1965
What is Revvity website?
https://www.perkinelmer.com
Is Revvity in the S&P 500?
Yes, Revvity is included in the S&P 500 index
Is Revvity in the NASDAQ 100?
No, Revvity is not included in the NASDAQ 100 index
Is Revvity in the Dow Jones?
No, Revvity is not included in the Dow Jones index
When does Revvity report earnings?
The next expected earnings date for Revvity is 01 August 2024